Doctor profile · Federal record
Dr. Juan Cattoni, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Reno, NV
- NPI 1881906121
- Accepts Medicare
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5423 Reno Corporate Dr.
Reno, NV 895112250
(775) 329-0873
fax (775) 329-1026 - Mailing address
-
5423 Reno Corporate Dr
Reno, NV 895112250
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- May 22, 2019
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #16625
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881906121. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
60,631
Distinct HCPCS
10
Medicare allowed
$1,565,983
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9263 |
Injection, oxaliplatin, 0.5 mg | 14,000 | 16 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 12,400 | 18 | $54 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,820 | 15 | $45 | |
J0185 |
Injection, aprepitant, 1 mg | 6,240 | 22 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 2,700 | 14 | $23 | |
J0894 |
Injection, decitabine, 1 mg | 2,650 | 16 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,069 | 85 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,820 | 13 | $6 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,490 | 68 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,189 | 407 | $127 |
In context: peer comparison
Among 8 peers in Reno Hematology & Oncology Physician, average services per provider: 1,102. This provider delivers 55× the peer median.Open Payments
Industry payments received
All-time total
$930
Transactions
28
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | 1 | $111.89 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $110.11 | |
| Novartis Pharmaceuticals Corporation | 4 | $83.87 | |
| Daiichi Sankyo INC. | 3 | $73.35 | |
| SpringWorks Therapeutics, INC. | 2 | $58.26 | |
| Pfizer INC. | 2 | $52.57 | |
| Astellas Pharma US INC | 2 | $50.91 | |
| Mirati Therapeutics, INC. | 2 | $49.99 | |
| Array Biopharma INC | 2 | $49.96 | |
| Incyte Corporation | 1 | $29.82 | |
| Kyowa Kirin, INC. | 1 | $28.30 | |
| PharmaEssentia USA Corporation | 1 | $27.57 | |
| Taiho Oncology, INC. | 1 | $27.54 | |
| Alexion Pharmaceuticals, INC. | 1 | $25.13 | |
| Emd Serono, INC. | 1 | $24.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
721
Patients
118
Total drug cost
$2,713,535
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 103 | 29 | $2,719 |
| Hydroxyurea | Generic | 95 | 22 | $4,470 |
| Alendronate Sodium | Generic | 67 | 26 | $946 |
| Eliquis (Apixaban) | Brand | 65 | 13 | $48,120 |
| Revlimid (Lenalidomide) | Brand | 60 | 0 | $914,752 |
| Acyclovir | Generic | 58 | 13 | $1,081 |
| Imbruvica (Ibrutinib) | Brand | 42 | 0 | $671,611 |
| Abiraterone Acetate | Generic | 33 | 0 | $91,420 |
| Dexamethasone | Generic | 31 | 15 | $477 |
| Prednisone | Generic | 30 | 0 | $167 |
Hospital affiliations
Frequently asked questions
What is Dr. Juan Cattoni's medical specialty?
Dr. Juan Cattoni practices Hematology & Oncology Physician in Reno, NV.
Where does Dr. Juan Cattoni practice?
Dr. Juan Cattoni practices at 5423 Reno Corporate Dr., Reno, NV 895112250. Office phone: 7753290873.
What is Dr. Juan Cattoni's NPI?
Dr. Juan Cattoni's National Provider Identifier (NPI) is 1881906121, issued by NPPES.
Does Dr. Juan Cattoni accept Medicare assignment?
Yes. Dr. Juan Cattoni accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Juan Cattoni commonly perform?
Top Medicare-reported procedures in 2023: Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.